Colton Thomas
Charged Alpha Stock Encyclopedia
Charged Alpha reviews earnings for each stock in the Russel 1000 every quarter. Each podcast gives thorough analysis, along with an in-depth profile in the beginning of the episode of the company, what they do, how they earn money and what to look for.
Husk at besøge podcastens hjemmeside og støtte skaberen: chargedalpha.podbean.com
Forfatter
Colton Thomas
Kategori
Podcastens hjemmeside
Seneste episode
28. okt. 2026
Hvor kan du lytte?
Podcasts i appen Replaio Radio Kommer snartPodcasts kommer snart til appen. Installer nu, og vær den første til at se en helt ny tilgang til podcasts
Episoder
FEIM Stock: A Record Backlog and an Ugly Quarter — Buy the Dip? 16.07.2026 12:57
Frequency Electronics (FEIM) Q4 FY2026 — Frequency Electronics (FEIM) — a niche maker of atomic clocks and precision timing for satellites, missiles and secure military comms — reported an ugly fiscal Q4: gross margin collapsed to ~1% (vs a normal ~30%) and EPS came in at -$0.50 versus a +$0.27 estimate, a big miss, on a $3.8M Elcom inventory write-down and pre-revenue investment. Strip the one-of...
BMNR Stock: A Dollar of Ethereum for 87 Cents — Bargain or Trap? 16.07.2026 9:51
BitMine Immersion Technologies (BMNR) Q3 FY2026 — BitMine Immersion (BMNR), the largest corporate holder of Ethereum on earth (~5% of all ETH), trades at roughly a 13% discount to the value of its own coins — you buy a dollar of Ethereum for about 87 cents. But it carries an ~$8.2B unrealized loss from buying ETH near the top, and funds itself with 12%-cost preferred to earn a 2.7% staking yield....
PAC Stock: This Airport Grew Profit While Traffic Fell — Here’s How 15.07.2026 13:28
Grupo Aeroportuario del Pacífico (PAC) Q2 2026 — Grupo Aeroportuario del Pacífico (GAP), the Mexican airport operator, grew Q2 2026 EBITDA 8.4% to a record 69% margin and net income 9% — even as passenger traffic fell 5.6% — but the stock was labeled an earnings 'miss' because per-share profit fell ~7% after it issued ~90M shares (+17.7%) to buy full control of the CBX border bridge. The ADR was r...
ANGO Stock: AngioDynamics Jumped 11% — Because Medicare Said Yes 15.07.2026 14:59
AngioDynamics (ANGO) Q4 FY2026 — AngioDynamics beat on its fiscal Q4 (revenue $86.6M, +8%; adjusted loss of $0.07, 4 cents better than feared), grew full-year Med Tech 18%, and guided FY27 revenue above consensus. The stock jumped ~11% to a 52-week high, led by NanoKnife (+64.5%) as Medicare coverage for its prostate-ablation therapy went live July 5. AngioDynamics quietly reinvented itself: it so...
PXED Stock: University of Phoenix Trades at 7x Earnings — and Fears One Number 15.07.2026 9:51
Phoenix Education Partners (PXED) Q3 FY2026 — Phoenix Education Partners (parent of the University of Phoenix) reported flat Q3 revenue of $271.8M, beat on adjusted EPS at $1.43, but cut its full-year revenue guide and saw margins compress — blaming AI-powered search for disrupting its student-recruitment funnel. The stock fell ~9.5% to ~$31. The single number that governs this stock: 88.6% of Pho...
ERIC Stock: Ericsson Beat on Profit and Fell 13% — Blame AI 15.07.2026 14:00
Ericsson (ERIC) Q2 2026 — Ericsson's Q2 2026 adjusted gross margin rose to 48.4% (Networks 50.4%, a multi-year high) and EPS met consensus, but the ADR fell ~13% — its worst earnings reaction in three years — after management warned that AI-driven memory and component cost inflation will squeeze Q3 Networks margins to 48-50%, revenue came in light, and North America declined. Ericsson beat on prof...
FAST Stock: Fastenal Is a Wonderful Business — But Is It a Buy at This Price? 15.07.2026 13:40
Fastenal Company (FAST) Q2 2026 — Fastenal grew Q2 2026 revenue 14.7% to $2.39B with daily sales up 14.7%, but EPS of $0.33 only met consensus, gross margin fell 75bps to 44.6% on tariff costs, and it trimmed two full-year targets. The stock slipped ~2.2% to ~$44.75. Nobody disputes Fastenal is a wonderful business — 31% return on capital, a genuine vending-machine and Onsite moat, a fortress bala...
KMTS Stock: This Medtech Grew 66% and Fell 8% — Here’s Why 15.07.2026 16:11
Kestra Medical Technologies (KMTS) Q4 FY2026 — Kestra Medical grew fiscal Q4 revenue 66% to $28.6M (FY26 +59% to $95.1M) and expanded gross margin to 54.8% — its 10th straight quarter of gains — but its adjusted EBITDA loss widened to $27M, EPS missed, and it guided FY27 revenue to $137M (+44%, a deceleration). The stock fell ~8.5% to ~$22. Kestra makes the ASSURE wearable defibrillator and is the...
AEHR Stock: The AI Burn-In Company Just Guided to Triple — Is It a Buy? 15.07.2026 12:44
Aehr Test Systems (AEHR) Q4 FY2026 — Aehr Test Systems beat on its fiscal Q4 (revenue $18.8M, +34%; non-GAAP EPS $0.11 vs a small expected loss), posted record bookings of $60.7M and a $100.6M effective backlog, and guided fiscal 2027 revenue to $130-150M — 160-200% growth. The stock rose ~6% to $72. Going into the print, Aehr was the classic story stock: 52x sales, falling revenue, and no FY27 nu...
AERO Stock: Aeroméxico Posted Record Revenue — and Still Lost $58 Million 13.07.2026 12:57
Grupo Aeroméxico (AERO) Q2 2026 — Aeroméxico posted a record second-quarter revenue of $1.479B (+12.6%) on capacity up just 1.9% — and still swung to a $58M net loss, as jet fuel expense jumped 79.9% to $494M. The stock fell 8.5% to $15.30, now 25% below its November IPO price. Aeroméxico's board policy permits hedging 40-60% of its jet fuel. It has hedged ZERO for six straight years — and this wa...
DAL Stock: Delta Posted Record Revenue and Beat — So Why Did It Fall? 10.07.2026 13:20
Delta Air Lines (DAL) Q2 2026 — Delta posted record adjusted revenue of $17.7B (+14%) and beat with adjusted EPS of $1.56 — but EPS fell 26% YoY on the highest quarterly fuel bill in its history, it affirmed rather than raised full-year guidance, and the stock slipped ~2% after a 76% run to record highs. Delta is no longer a commodity airline — premium cabins now out-earn the main cabin, the Ameri...
NRIX Stock: Nurix Tripled After a $700M Roche Deal — Is the Good News Already Priced In? 10.07.2026 13:32
Nurix Therapeutics (NRIX) Q2 FY2026 — Nurix Therapeutics reported a fiscal Q2 net loss of $(0.81) per share on ~$9M of collaboration revenue — but the story is the June Roche partnership on its BTK degrader bexobrutideg ($700M upfront, up to $2.3B), which lifts pro-forma cash to ~$1.14B and has driven the stock ~200% off its lows to near $25. Nurix is a clinical-stage protein-degradation biotech w...
WDFC Stock: WD-40 Crushed Earnings and Popped 15% — But Is a Cult Brand Worth 40x? 10.07.2026 12:52
WD-40 Company (WDFC) Q3 FY2026 — WD-40 grew fiscal Q3 sales 24% to $195M, delivered adjusted EPS of $2.33 (GAAP $2.24) that crushed the ~$1.58 estimate, raised full-year guidance and added a $100M buyback — sending the stock ~15% higher to a fresh all-time high near $276. WD-40 is a genuinely wide-moat cult brand — ~85% awareness, 56%+ gross margins, real pricing power, and a global runway — that...
SMPL Stock: Simply Good Foods Beat Earnings but Sales Fell — Cheap Turnaround or Value Trap? 09.07.2026 12:43
Simply Good Foods (SMPL) Q3 FY2026 — Simply Good Foods (Quest, Atkins, OWYN) beat with adjusted EPS of $0.42 vs $0.35, but net sales fell 6% to $357M, an $82M impairment drove a GAAP loss of $(0.58), Atkins collapsed 24.6%, and full-year guidance implies a down year. Simply Good Foods has fallen ~62% from ~$34 to ~$13. It's cheap (~6x EV/EBITDA), cash-generative, and squarely in the protein-snacki...
AZZ Stock: The Boring Industrial That Beat, Raised Guidance, and Jumped 7% 09.07.2026 12:31
AZZ Inc. (AZZ) Q1 FY2027 — AZZ — North America's largest independent hot-dip galvanizer — grew Q1 sales 6.3% to a record $448.5M, beat with adjusted EPS of $1.85, raised full-year guidance on all three metrics, and hiked its dividend 20%; the stock jumped ~7% after hours. AZZ is a high-margin, essential industrial — galvanizing and coil coating that keeps steel from rusting — riding an infrastruct...
PSMT Stock: The ’Costco of Latin America’ Keeps Compounding — But Is It Too Expensive? 09.07.2026 11:44
PriceSmart (PSMT) Q3 FY2026 — PriceSmart grew Q3 revenue 12.5% to ~$1.48B with comparable sales up 10.7%, but adjusted EPS of $1.28 landed just short of the ~$1.32 estimate and the stock — near an all-time high at ~37x earnings — dipped slightly. PriceSmart is the 'Costco of Latin America' — 57 membership warehouse clubs across 12 countries, a sticky membership annuity, a net-cash balance sheet, a...
LEVI Stock: Levi Strauss Beat and Raised Guidance — So Why Did It Drop 5%? 09.07.2026 11:46
Levi Strauss (LEVI) Q2 FY2026 — Levi Strauss beat on Q2 sales (+8% to $1.56B) and adjusted EPS ($0.28, +27%), raised full-year guidance for the fourth straight time and hiked its dividend 14% — yet the stock fell ~5% because the raised EPS midpoint (~$1.49) landed just below the most bullish estimates after a near-double off the lows. Levi's has transformed into a DTC-led denim-lifestyle brand — d...
HELE Stock: Helen of Troy Fell 80% and Beat Earnings — So Why Did It Drop 10%? 09.07.2026 12:37
Helen of Troy (HELE) Q1 FY2027 — Helen of Troy — owner of OXO, Hydro Flask, Osprey and Vicks — grew Q1 sales +8% and beat a rock-bottom estimate, but adjusted EPS fell 58% to $0.17 and the stock dropped ~10% to ~$25, down over 80% from its peak. Helen of Troy trades at roughly 7x forward earnings after an 80%+ collapse — a portfolio of genuinely good brands wrapped in ~3.5x leverage, tariff exposu...
GIS Stock: General Mills Yields 6.6% After a 30% Drop — Value Buy or Value Trap? 08.07.2026 10:57
General Mills (GIS) Q4 FY2026 — FY2026 net sales fell 5% (organic -2%) and adjusted EPS dropped 16% to $3.55 amid soft volumes, private label, and GLP-1 fears — and the stock has slid ~30% to ~$37, pushing the yield to ~6.6%. General Mills (Cheerios, Blue Buffalo, Betty Crocker) has been cut down to ~$37 (~10x earnings, ~6.6% covered yield) on real packaged-food headwinds. But the market is pricin...
FDS Stock: FactSet Got Cut in Half on AI Fears — Is This Wide-Moat Compounder a Buy? 08.07.2026 10:57
FactSet (FDS) Q3 FY2026 — FactSet fell ~60% from its 2025 high (~$450) to ~$185 on AI-disruption fears — but Q3 revenue rose 6.4%, organic ASV grew 7.1%, EPS beat, and guidance was reaffirmed. FactSet is a wide-moat financial-data compounder (recurring ASV, ~34% margins, 27 straight years of dividend increases) that got de-rated from ~30x to ~15x on fears that AI kills the data terminal. The Q3 nu...
MSM Stock: MSC Industrial Ripped 40% on a Real Recovery — But Is It Too Late to Buy? 08.07.2026 10:45
MSC Industrial (MSM) Q3 FY2026 — Q3 sales rose 7.8% to $1.05B and EPS jumped 41% to $1.44 as adjusted operating margin expanded to 10.6% — and the stock has run 40%+ off its lows to ~$120. MSC Industrial is a textbook cyclical recovery: sales re-accelerating (+4% → +7.8%), margins climbing (8.4% → 10.6%), EPS +41%. The catch is the price — the stock has run 40%+ to ~25x forward, and the Street's a...
UNF Stock: UniFirst Is Being Bought by Cintas — Is the 8% Merger Spread Worth the FTC Risk? 08.07.2026 9:33
UniFirst (UNF) Q3 FY2026 — UniFirst is being acquired by Cintas for $155 cash + 0.772 Cintas shares (~$295 today), but the stock trades near $274 — an ~8% spread reflecting FTC antitrust risk after a June 11 Second Request. This isn't a fundamentals story anymore — it's a merger-arbitrage bet. Cintas, the #1 uniform-rental company, is buying UniFirst. Shareholders approved on June 11, but the FTC...
LNN Stock: Lindsay Is a Quality Compounder in a Farm Slump — But Is It Too Expensive? 08.07.2026 13:13
Lindsay (LNN) Q3 FY2026 — Revenue fell 5% to $160.8M and EPS slipped to $1.53 as the ag down-cycle pressured irrigation, while infrastructure grew 8% and the MENA project lifted backlog. Lindsay is a rare thing: a net-cash, moat-owning compounder (Zimmatic irrigation + the Road Zipper) aggressively buying back its own stock right through a farm recession. The catch is the price — roughly 23x troug...
GBX Stock: Greenbrier’s Earnings Cratered and Wall Street Says Sell — Is the Bottom a Buy? 08.07.2026 9:49
Greenbrier (GBX) Q3 FY2026 — Revenue fell 32% to $576.5M and missed estimates, EPS dropped to $0.60, and management trimmed full-year guidance — but the lease fleet grew 23% at 99% utilization. Greenbrier's earnings have collapsed from $6.35 a share last year toward ~$3 this year, guidance was just cut, and the Street rates it a Sell. Yet it's quietly becoming a rail-leasing company, trades below...
FIZZ Stock: The LaCroix Company Just Paid a Huge Special Dividend — Is It a Buy? (FY2026) 08.07.2026 9:17
National Beverage (FIZZ) FY2026 — Shares popped double digits after National Beverage declared a $3.25/share special dividend — roughly 10% of the stock — even as case volumes fell 6.7%. The maker of LaCroix is one of the most under-covered stocks on the market: founder Nick Caporella owns ~73%, management holds no earnings calls, and almost no Wall Street analyst follows it. Sales were flat, volu...
Lignende podcasts
Replaio er ikke podcastudgiver; programmernes navne, coverbilleder og lyd tilhører deres ophavsmænd og distribueres via offentlige RSS-feeds.